LTFS
KITE

Ladenburg Thalmann Financial Services’s Kite Pharma, Inc. KITE Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,123
Closed -$202K – 5263
2017
Q3 		$202K Sell
1,123
-1,963
-64% -$274K ﹤0.01% 2102
2017
Q2 		$320K Buy
3,086
+627
+25% +$51.2K ﹤0.01% 1698
2017
Q1 		$193K Buy
2,459
+975
+66% +$60.3K ﹤0.01% 1940
2016
Q4 		$66K Buy
1,484
+284
+24% +$13.9K ﹤0.01% 2649
2016
Q3 		$67K Buy
1,200
+100
+9% +$5.57K ﹤0.01% 2564
2016
Q2 		$55K Buy
1,100
+200
+22% +$9.83K ﹤0.01% 2607
2016
Q1 		$41K Buy
900
+100
+13% +$4.84K ﹤0.01% 2749
2015
Q4 		$49K Buy
800
+125
+19% +$8.8K ﹤0.01% 2578
2015
Q3 		$38K Buy
675
+575
+575% +$36.2K ﹤0.01% 2664
2015
Q2 		$6K Sell
100
-147
-60% -$8.39K ﹤0.01% 4009
2015
Q1 		$14K Buy
+247
New +$16.6K ﹤0.01% 3434

Ladenburg Thalmann Financial Services's KITE Position: Q4 2017 in Review

Ladenburg Thalmann Financial Services sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 1,123 shares — an estimated $202K sold.

Ladenburg Thalmann Financial Services first reported a position in KITE in Q1 2015 and held it in 11 quarters. The position peaked at $320K in Q2 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Ladenburg Thalmann Financial Services reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 1,123 Kite Pharma, Inc. shares in Q4 2017, an estimated $202K.
  • Ladenburg Thalmann Financial Services first reported a position in Kite Pharma, Inc. in Q1 2015 and held it in 11 quarters.
  • Ladenburg Thalmann Financial Services's Kite Pharma, Inc. position peaked at $320K in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2017, filed 14 Feb 2018.